77 related articles for article (PubMed ID: 9252959)
41. Antitumor activity of synthetic alkylphospholipids with or without PAF activity.
Kudo I; Nojima S; Chang HW; Yanoshita R; Hayashi H; Kondo E; Nomura H; Inoue K
Lipids; 1987 Nov; 22(11):862-7. PubMed ID: 3444379
[TBL] [Abstract][Full Text] [Related]
42. Ether lipids inhibit the effects of phorbol diester tumor promoters.
Daniel LW; Etkin LA; Morrison BT; Parker J; Morris-Natschke S; Surles JR; Piantadosi C
Lipids; 1987 Nov; 22(11):851-5. PubMed ID: 3444377
[TBL] [Abstract][Full Text] [Related]
43. A metabolite of an antineoplastic ether phospholipid may inhibit transmembrane signalling via protein kinase C.
van Blitterswijk WJ; van der Bend RL; Kramer IM; Verhoeven AJ; Hilkmann H; de Widt J
Lipids; 1987 Nov; 22(11):842-6. PubMed ID: 3444375
[TBL] [Abstract][Full Text] [Related]
44. Increased membrane permeability for an antitumoral alkyl lysophospholipid in sensitive tumor cells.
Storch J; Munder PG
Lipids; 1987 Nov; 22(11):813-9. PubMed ID: 3444371
[TBL] [Abstract][Full Text] [Related]
45. The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D.
Wilcox RW; Wykle RL; Schmitt JD; Daniel LW
Lipids; 1987 Nov; 22(11):800-7. PubMed ID: 3444369
[TBL] [Abstract][Full Text] [Related]
46. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro.
Berdel WE; Korth R; Reichert A; Houlihan WJ; Bicker U; Nomura H; Vogler WR; Benveniste J; Rastetter J
Anticancer Res; 1987; 7(6):1181-7. PubMed ID: 3442414
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and evaluation of neoplastic cell growth inhibition of 1-N-alkylamide analogues of glycero-3-phosphocholine.
Marx MH; Piantadosi C; Noseda A; Daniel LW; Modest EJ
J Med Chem; 1988 Apr; 31(4):858-63. PubMed ID: 3162534
[TBL] [Abstract][Full Text] [Related]
48. Evidence of protein kinase C involvement in phorbol diester-stimulated arachidonic acid release and prostaglandin synthesis.
Parker J; Daniel LW; Waite M
J Biol Chem; 1987 Apr; 262(11):5385-93. PubMed ID: 3104333
[TBL] [Abstract][Full Text] [Related]
49. A novel mechanism of diglyceride formation. 12-O-tetradecanoylphorbol-13-acetate stimulates the cyclic breakdown and resynthesis of phosphatidylcholine.
Daniel LW; Waite M; Wykle RL
J Biol Chem; 1986 Jul; 261(20):9128-32. PubMed ID: 3087989
[TBL] [Abstract][Full Text] [Related]
50. Ether lipids in the therapy of cancer.
Andreesen R
Prog Biochem Pharmacol; 1988; 22():118-31. PubMed ID: 3043427
[No Abstract] [Full Text] [Related]
51. Increased cellular internalization of amphiphiles in a multidrug-resistant CHO cell line.
Boscoboinik D; Epand RM
Biochim Biophys Acta; 1989 Oct; 1014(1):53-6. PubMed ID: 2804090
[TBL] [Abstract][Full Text] [Related]
52. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Chabot MC; Wykle RL; Modest EJ; Daniel LW
Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
[TBL] [Abstract][Full Text] [Related]
53. Differences in intracellular transport of a fluorescent phosphatidylcholine analog in established cell lines.
Sleight RG; Abanto MN
J Cell Sci; 1989 Jun; 93 ( Pt 2)():363-74. PubMed ID: 2613764
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of growth factor-dependent inositol phosphate Ca2+ signaling by antitumor ether lipid analogues.
Seewald MJ; Olsen RA; Sehgal I; Melder DC; Modest EJ; Powis G
Cancer Res; 1990 Aug; 50(15):4458-63. PubMed ID: 2369723
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and biological activity of novel quaternary ammonium derivatives of alkylglycerols as potent inhibitors of protein kinase C.
Marasco CJ; Piantadosi C; Meyer KL; Morris-Natschke S; Ishaq KS; Small GW; Daniel LW
J Med Chem; 1990 Mar; 33(3):985-92. PubMed ID: 2308148
[TBL] [Abstract][Full Text] [Related]
56. Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells.
Bazill GW; Dexter TM
Cancer Res; 1990 Dec; 50(23):7505-12. PubMed ID: 2253199
[TBL] [Abstract][Full Text] [Related]
57. Cross-resistance pattern of cell lines selected for resistance towards different cytotoxic drugs to membrane-toxic phospholipids in vitro.
Himmelmann AW; Danhauser-Riedl S; Steinhauser G; Busch R; Modest EJ; Noseda A; Rastetter J; Vogler WR; Berdel WE
Cancer Chemother Pharmacol; 1990; 26(6):437-43. PubMed ID: 2225315
[TBL] [Abstract][Full Text] [Related]
58. Alteration of intracellular traffic by monensin; mechanism, specificity and relationship to toxicity.
Mollenhauer HH; Morré DJ; Rowe LD
Biochim Biophys Acta; 1990 May; 1031(2):225-46. PubMed ID: 2160275
[TBL] [Abstract][Full Text] [Related]
59. Selective modulation of the endocytic uptake of ricin and fluid phase markers without alteration in transferrin endocytosis.
Sandvig K; van Deurs B
J Biol Chem; 1990 Apr; 265(11):6382-8. PubMed ID: 1969411
[TBL] [Abstract][Full Text] [Related]
60. Membrane-interactive lipids as experimental anticancer drugs.
Berdel WE
Br J Cancer; 1991 Aug; 64(2):208-11. PubMed ID: 1892746
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
